XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Preferred Shares
Common Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Distributions in Excess of Retained Earnings
Total Shareholders' Equity
Non-Controlling Interests
Preferred stock, beginning balance (in shares) at Dec. 31, 2017   10,000,000            
Common stock, beginning balance (in shares) at Dec. 31, 2017     68,812,575          
Beginning balance at Dec. 31, 2017 $ 1,503,526 $ 100 $ 688 $ 1,685,437 $ 3,689 $ (191,013) $ 1,498,901 $ 4,625
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common shares for Board of Trustees compensation (in shares)     17,410          
Issuance of common shares for Board of Trustees compensation 662   $ 1 661     662  
Repurchase of common shares (in shares)     (69,687)          
Repurchase of common shares (2,507)   $ (1) (2,506)     (2,507)  
Share-based compensation (in shares)     151,887          
Share-based compensation (269)   $ 1 (546)     (545) 276
Distributions on common shares/units (26,274)         (26,184) (26,184) (90)
Distributions on preferred shares (4,023)         (4,023) (4,023)  
Other comprehensive income (loss):                
Unrealized gain (loss) on derivative instruments 5,278       5,278   5,278  
Unrealized gain (loss) on marketable securities (579)       (579)   (579)  
Net income (loss) 24,516         24,409 24,409 107
Preferred stock, ending balance (in shares) at Mar. 31, 2018   10,000,000            
Common stock, ending balance (in shares) at Mar. 31, 2018     68,912,185          
Ending balance at Mar. 31, 2018 $ 1,500,330 $ 100 $ 689 1,683,046 8,936 (197,359) 1,495,412 4,918
Preferred stock, beginning balance (in shares) at Dec. 31, 2018 20,400,000 20,400,000            
Common stock, beginning balance (in shares) at Dec. 31, 2018 130,311,289   130,311,289          
Beginning balance at Dec. 31, 2018 $ 3,769,930 $ 204 $ 1,303 4,065,804 1,330 (308,806) 3,759,835 10,095
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares, net of offering costs (275)     (275)     (275)  
Issuance of common shares for Board of Trustees compensation (in shares)     25,282          
Issuance of common shares for Board of Trustees compensation 740   $ 1 739     740  
Repurchase of common shares (in shares)     (126,681)          
Repurchase of common shares (4,009)   $ (1) (4,008)     (4,009)  
Share-based compensation (in shares)     275,066          
Share-based compensation 1,848   $ 2 1,570     1,572 276
Distributions on common shares/units (49,912)         (49,771) (49,771) (141)
Distributions on preferred shares (8,139)         (8,139) (8,139)  
Other comprehensive income (loss):                
Unrealized gain (loss) on derivative instruments (9,039)       (9,039)   (9,039)  
Unrealized gain (loss) on marketable securities 0              
Net income (loss) $ 5,655         5,635 5,635 20
Preferred stock, ending balance (in shares) at Mar. 31, 2019 20,400,000 20,400,000            
Common stock, ending balance (in shares) at Mar. 31, 2019 130,484,956   130,484,956          
Ending balance at Mar. 31, 2019 $ 3,706,799 $ 204 $ 1,305 $ 4,063,830 $ (7,709) $ (361,081) $ 3,696,549 $ 10,250